Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Eftimov

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|March 15, 2024
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infectionSofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, et al.
Brain : a Journal of Neurology|February 9, 2022
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyMax E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, et al.
Seminars in Hematology|May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathyShirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Annals of Neurology|October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple SclerosisZoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2026
Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trialSander R M Bus, Iris N van Doorn, Laura Zambreanu, et al.
Journal of the Peripheral Nervous System : JPNS|June 4, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
European Journal of Neurology|July 30, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
The Lancet. Neurology|February 6, 2010
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trialIvo N van Schaik, Filip Eftimov, Pieter A van Doorn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2023
Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohortMerel C Broers, Luuk Wieske, Ece Erdag, et al.
Frontiers in Immunology|January 1, 2025
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infectionLisan H Kuijper, Christine Kreher, George Elias, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|March 15, 2024
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infectionSofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, et al.
Brain : a Journal of Neurology|February 9, 2022
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyMax E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, et al.
Seminars in Hematology|May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathyShirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Annals of Neurology|October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple SclerosisZoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 27, 2026
Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trialSander R M Bus, Iris N van Doorn, Laura Zambreanu, et al.
Journal of the Peripheral Nervous System : JPNS|June 4, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
European Journal of Neurology|July 30, 2021
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revisionPeter Y K Van den Bergh, Pieter A van Doorn, Robert D M Hadden, et al.
The Lancet. Neurology|February 6, 2010
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trialIvo N van Schaik, Filip Eftimov, Pieter A van Doorn, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2023
Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohortMerel C Broers, Luuk Wieske, Ece Erdag, et al.
Frontiers in Immunology|January 1, 2025
Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infectionLisan H Kuijper, Christine Kreher, George Elias, et al.
Pageof 10